Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Combe

Showing results (1-10 of 316) with videos related to

Pageof 32
Sort By:
Joint Bone Spine|June 9, 2004
Switching between anti-TNFalpha agents: what is the evidence?Bernard Combe
Clinical and Experimental Rheumatology|June 26, 2010
Impact of dosing on treatment with TNF inhibitors: managing dose adjustmentBernard Combe
Joint Bone Spine|October 31, 2006
Leflunomide combined with conventional disease-modifying antirheumatic drugs or biologics in patients with rheumatoid arthritisBernard Combe
Joint Bone Spine|December 14, 2004
Should patients with recent-onset polyarthritis receive aggressive treatment?Bernard Combe
Biologics : Targets & Therapy|August 27, 2009
Update on the use of etanercept across a spectrum of rheumatoid disordersBernard Combe
Joint Bone Spine|November 15, 2011
The new classification criteria for rheumatoid arthritis and their impact on therapeutic decisionsBernard Combe
Bulletin De L'Academie Nationale De Medecine|July 3, 2013
[Indications and efficacy of biologics in inflammatory arthritis]Bernard Combe
Best Practice & Research. Clinical Rheumatology|March 14, 2007
Early rheumatoid arthritis: strategies for prevention and managementBernard Combe
Best Practice & Research. Clinical Rheumatology|February 24, 2009
Progression in early rheumatoid arthritisBernard Combe
La Revue Du Praticien|May 30, 2006
[Rheumatoid arthritis]Jacques Morel, Bernard Combe
Pageof 32

Showing results (1-10 of 316) with videos related to

Sort By:
Pageof 32
Joint Bone Spine|June 9, 2004
Switching between anti-TNFalpha agents: what is the evidence?Bernard Combe
Clinical and Experimental Rheumatology|June 26, 2010
Impact of dosing on treatment with TNF inhibitors: managing dose adjustmentBernard Combe
Joint Bone Spine|October 31, 2006
Leflunomide combined with conventional disease-modifying antirheumatic drugs or biologics in patients with rheumatoid arthritisBernard Combe
Joint Bone Spine|December 14, 2004
Should patients with recent-onset polyarthritis receive aggressive treatment?Bernard Combe
Biologics : Targets & Therapy|August 27, 2009
Update on the use of etanercept across a spectrum of rheumatoid disordersBernard Combe
Joint Bone Spine|November 15, 2011
The new classification criteria for rheumatoid arthritis and their impact on therapeutic decisionsBernard Combe
Bulletin De L'Academie Nationale De Medecine|July 3, 2013
[Indications and efficacy of biologics in inflammatory arthritis]Bernard Combe
Best Practice & Research. Clinical Rheumatology|March 14, 2007
Early rheumatoid arthritis: strategies for prevention and managementBernard Combe
Best Practice & Research. Clinical Rheumatology|February 24, 2009
Progression in early rheumatoid arthritisBernard Combe
La Revue Du Praticien|May 30, 2006
[Rheumatoid arthritis]Jacques Morel, Bernard Combe
Pageof 32